We appear to be headed in the direction of cardiologists understanding more about the impact of thyroid hormones than endocrinologists.
Unfortunately, the rest of this paper is behind a paywall.
Thyroid Hormones and Cardiovascular Function and Diseases
Salman Razvi, MDa, b, , , Avais Jabbar, MDa, c, Alessandro Pingitore, MDd, Sara Danzi, PhDe, Bernadette Biondi, MDf, Irwin Klein, MDg, Robin Peeters, MDh, Azfar Zaman, MDc, i, Giorgio Iervasi, MDd
Get rights and content
Thyroid hormone (TH) receptors are present in the myocardium and vascular tissue, and minor alterations in TH concentration can affect cardiovascular (CV) physiology. The potential mechanisms that link CV disease with thyroid dysfunction are endothelial dysfunction, changes in blood pressure, myocardial systolic and diastolic dysfunction, and dyslipidemia. In addition, cardiac disease itself may lead to alterations in TH concentrations (notably, low triiodothyronine syndrome) that are associated with higher morbidity and mortality. Experimental data and small clinical trials have suggested a beneficial role of TH in ameliorating CV disease. The aim of this review is to provide clinicians dealing with CV conditions with an overview of the current knowledge of TH perturbations in CV disease.
21/04/2018 21:58 Edited to add:
The eagle-eyed among you might notice that the picture accompanying this post (taken from the actual paper) does NOT mentioned TRH. Which is the subject of another of my very recent posts: